Zamaneh Mikhak is Chief Medical Officer of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 145,184 shares of TFFP, which is worth approximately $362,960. The most recent transaction as insider was on Jul 03, 2024, when has been sold 10,184 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 145K
0% 3M change
7.54% 12M change
Total Value Held $362,960

Zamaneh Mikhak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2024
BUY
Grant, award, or other acquisition
-
10,184 Added 6.55%
145,184 Common Stock
Aug 15 2023
BUY
Open market or private purchase
$30,000 $0.25 p/Share
120,000 Added 47.06%
135,000 Common Stock
Mar 10 2023
BUY
Open market or private purchase
$12,300 $0.82 p/Share
15,000 Added 50.0%
15,000 Common Stock
ZM

Zamaneh Mikhak

Chief Medical Officer
Fort Worth, TX

Track Institutional and Insider Activities on TFFP

Follow TFF Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFFP shares.

Notify only if

Insider Trading

Get notified when an Tff Pharmaceuticals, Inc. insider buys or sells TFFP shares.

Notify only if

News

Receive news related to TFF Pharmaceuticals, Inc.

Track Activities on TFFP